IRIS
VIOLA, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 612
NA - Nord America 596
AS - Asia 188
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 595
IE - Irlanda 237
SE - Svezia 181
IT - Italia 127
SG - Singapore 95
CN - Cina 77
DE - Germania 15
PL - Polonia 13
FI - Finlandia 11
FR - Francia 9
IN - India 8
AT - Austria 5
BE - Belgio 4
ID - Indonesia 4
GB - Regno Unito 3
BR - Brasile 2
HK - Hong Kong 2
NL - Olanda 2
AR - Argentina 1
BG - Bulgaria 1
CA - Canada 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
RO - Romania 1
UA - Ucraina 1
VN - Vietnam 1
Totale 1.400
Salva come PNG Salva come JPEG
Città #
Dublin 235
Chandler 169
Nyköping 94
Singapore 79
Ashburn 65
Princeton 37
Medford 33
Des Moines 24
Messina 21
Ann Arbor 13
Los Angeles 11
Seattle 10
Beijing 9
Jinan 9
Dearborn 7
Milan 7
Munich 7
Rome 7
Pozzuolo Martesana 6
Wilmington 6
Hebei 5
Jacksonville 5
Nanjing 5
Vienna 5
Brussels 4
Cagliari 4
Haikou 4
Hangzhou 4
Jakarta 4
Pune 4
Shenyang 4
Tianjin 4
Bremen 3
Changsha 3
Fuzhou 3
Helsinki 3
Lappeenranta 3
Mineo 3
Ningbo 3
Trecastagni 3
Zhengzhou 3
Amsterdam 2
Boardman 2
Cambridge 2
Carini 2
Enna 2
Guangzhou 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Lanzhou 2
New York 2
Reggio Calabria 2
Reggio Nell'emilia 2
Squillace 2
Trezzo Sull'adda 2
Venaria Reale 2
Bagheria 1
Bitonto 1
Bucharest 1
Council Bluffs 1
Fairfield 1
Frankfurt am Main 1
Gurgaon 1
Hebi 1
Kunming 1
Lakeland 1
London 1
Nanchang 1
Nuremberg 1
Nürnberg 1
Ottawa 1
Padova 1
Prineville 1
Redwood City 1
San Mateo 1
Sanmenxia 1
Shanghai 1
Sofia 1
Sopron 1
Springfield 1
Taizhou 1
Tappahannock 1
Viersen 1
Vilnius 1
Vittoria 1
Totale 989
Salva come PNG Salva come JPEG
Nome #
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 76
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 60
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 59
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 58
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 57
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 54
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 49
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 49
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 46
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 44
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study 44
Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic 42
Tissue levels of Tumour Necrosis Factor-alpha as molecular biomarker of inflammation and prediction of sustained treatment response in patients with Ulcerative Colitis. 42
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 41
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 41
null 40
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 39
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 37
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI 37
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches 36
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 35
Incident Colorectal Cancer in Inflammatory Bowel Disease 35
Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn’s disease: Need for a multidisciplinary approach 34
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 33
null 33
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 31
Ménétrier's disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature 28
Letter: the clinical course of Crohn's disease—the Sicilian experience 25
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 23
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study 23
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases 22
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 21
Portal hypertensive enteropathy: multimodality assessment through computed tomography and magnetic resonance enterography 20
SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501 20
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 18
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease 17
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study 16
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective study 16
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease 15
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 14
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 11
Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study 11
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 10
DWI ratios at MR-Enterography: a new way for inflammation degree assessment in Crohn's disease patients? 10
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 9
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center 8
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 7
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease 7
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis 6
A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy 6
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks? 6
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19 5
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease 4
Corticosteroid use in patients with inflammatory bowel diseases: A real-life sub-analysis of the Italian DICE study 4
Standard Therapeutic Approach and New Therapies 3
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study 2
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 2
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study 1
Epidemiology and clinical course of late onset inflammatory bowel disease 1
Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms 1
Totale 1.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 3 8 4 3 0 8 7 7
2020/2021152 15 12 32 4 15 4 18 5 5 19 16 7
2021/2022287 5 31 3 2 8 4 14 10 11 74 21 104
2022/2023597 39 65 26 53 29 45 14 28 268 11 13 6
2023/2024256 20 29 36 54 14 23 7 15 0 33 8 17
2024/2025185 16 21 16 79 53 0 0 0 0 0 0 0
Totale 1.544